Cytocom Inc. sell Midas
Start price
18.02.21
/
50%
€9.20
Target price
18.02.22
-
Performance (%)
-68.91%
End price
29.08.21
€2.86
Summary
This prediction ended on 29.08.21 with a price of €2.86. The SELL prediction by Midas for Cytocom Inc. performed very well with a performance of -68.91%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytocom Inc. | - | - | - | - |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
Comments by Midas for this prediction
In the thread Cytocom Inc. diskutieren
Sell Cleveland Biolabs